Details of the Drug Combinations

General Information of This Drug (ID: DM0PIY6)

Drug Name

Picoplatin DM0PIY6

Synonyms

AMD 473; JM-473; ZD0473; (SP-4-3)-Amminedichloro(2-methylpyridine)platinium; Platinum, amminedichloro(2-methylpyridine)-, (SP-4-3)-; Picoplatin [INN:BAN]; UNII-B5TAN0L720; ZD 0473; AC1L42P3; B5TAN0L720; DB04874; Amminedichloro(2-methylpyridine)platinium; AN-30599; LS-184068; J-011604; azane; 2-methylpyridine; dichloride

Indication

Disease Entry	ICD 11	Status	REF
Colorectal cancer	2B91.Z	Phase 3	[1]
Ovarian cancer	2C73	Phase 3	[1]
Prostate cancer	2C82.0	Phase 3	[1]
Small-cell lung cancer	2C25.Y	Phase 3	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

464 Investigative Drug Combination(s) Consisting of This drug

Normalized Drug Combination Synergy Score

Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons.

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
ABIRATERONE + Picoplatin	DC61VMN	ABIRATERONE	Renal cell carcinoma (Cell Line: UO-31)	[2]
ABIRATERONE + Picoplatin	DC2OKH4	ABIRATERONE	Adenocarcinoma (Cell Line: DU-145)	[3]
ABIRATERONE + Picoplatin	DC1KMSQ	ABIRATERONE	Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)	[3]
Acetohexamide + Picoplatin	DC4YGSY	Acetohexamide	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Anamorelin + Picoplatin	DCZLF00	Anamorelin	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Anastrozole + Picoplatin	DCR18FB	Anastrozole	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[2]
AS-1949490 + Picoplatin	DC0JYRI	AS-1949490	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Bleomycin + Picoplatin	DCOQR2P	Bleomycin	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[3]
Brincidofovir + Picoplatin	DC3FTCO	Brincidofovir	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Cabazitaxel + Picoplatin	DCJ01ZQ	Cabazitaxel	Anaplastic large cell lymphoma (Cell Line: SR)	[2]
Cabazitaxel + Picoplatin	DCXOE2O	Cabazitaxel	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[2]
Crizotinib + Picoplatin	DCFQILX	Crizotinib	Astrocytoma (Cell Line: U251)	[2]
Crizotinib + Picoplatin	DCZWVLT	Crizotinib	Breast adenocarcinoma (Cell Line: MDA-MB-468)	[4]
Crizotinib + Picoplatin	DCTOLBG	Crizotinib	Carcinoma (Cell Line: RXF 393)	[4]
Crizotinib + Picoplatin	DCSF0KH	Crizotinib	Invasive ductal carcinoma (Cell Line: HS 578T)	[4]
Dacarbazine + Picoplatin	DCKVQKE	Dacarbazine	Anaplastic large cell lymphoma (Cell Line: SR)	[2]
Dacarbazine + Picoplatin	DC3U30K	Dacarbazine	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4)	[2]
Dantrolene + Picoplatin	DC7B039	Dantrolene	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Dexrazoxane + Picoplatin	DCUJ6GH	Dexrazoxane	Adult acute myeloid leukemia (Cell Line: HL-60(TB))	[2]
Dexrazoxane + Picoplatin	DCT3MUJ	Dexrazoxane	Chronic myelogenous leukemia (Cell Line: K-562)	[2]
Dexrazoxane + Picoplatin	DC2NHBR	Dexrazoxane	Clear cell renal cell carcinoma (Cell Line: TK-10)	[2]
Dexrazoxane + Picoplatin	DCTTHFW	Dexrazoxane	Breast adenocarcinoma (Cell Line: MDA-MB-468)	[4]
Dexrazoxane + Picoplatin	DCRD96U	Dexrazoxane	Invasive ductal carcinoma (Cell Line: BT-549)	[4]
Dexrazoxane + Picoplatin	DC6TAXI	Dexrazoxane	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4)	[3]
Dexrazoxane + Picoplatin	DC22OES	Dexrazoxane	Malignant melanoma (Cell Line: UACC62)	[3]
Dexrazoxane + Picoplatin	DC2WMFP	Dexrazoxane	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[3]
Diazoxide + Picoplatin	DCWI02C	Diazoxide	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Doxorubicin + Picoplatin	DC5IZLH	Doxorubicin	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Dronedarone + Picoplatin	DCFDBBU	Dronedarone	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Emetine + Picoplatin	DC6F2L1	Emetine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Epinephrine + Picoplatin	DCER8VX	Epinephrine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Epirubicin + Picoplatin	DC2IGA0	Epirubicin	Carcinoma (Cell Line: RXF 393)	[4]
Epirubicin + Picoplatin	DCIBMQY	Epirubicin	Invasive ductal carcinoma (Cell Line: HS 578T)	[4]
Epirubicin + Picoplatin	DCHYX1Q	Epirubicin	Adenocarcinoma (Cell Line: DU-145)	[3]
Epirubicin + Picoplatin	DCM4ULB	Epirubicin	Malignant melanoma (Cell Line: UACC62)	[3]
Gefitinib + Picoplatin	DCG96WT	Gefitinib	Adenocarcinoma (Cell Line: HT29)	[2]
Gefitinib + Picoplatin	DCGJKOD	Gefitinib	Anaplastic large cell lymphoma (Cell Line: SR)	[2]
Gefitinib + Picoplatin	DCAU74Z	Gefitinib	Glioma (Cell Line: SF-539)	[2]
Gefitinib + Picoplatin	DC5JMRI	Gefitinib	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[2]
Hydralazine + Picoplatin	DCO1UEO	Hydralazine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Hyodeoxycholic acid + Picoplatin	DCV2RZ8	Hyodeoxycholic acid	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Indazole derivative 5 + Picoplatin	DCTIH5X	Indazole derivative 5	Anaplastic large cell lymphoma (Cell Line: SR)	[2]
Indazole derivative 5 + Picoplatin	DC7ELMF	Indazole derivative 5	Invasive ductal carcinoma (Cell Line: T-47D)	[4]
Indazole derivative 5 + Picoplatin	DC6BKTF	Indazole derivative 5	Non-small cell lung carcinoma (Cell Line: HOP-92)	[3]
L-165041 + Picoplatin	DC6G8SD	L-165041	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Lacosamide + Picoplatin	DC110EM	Lacosamide	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Lenalidomide + Picoplatin	DCC1CEA	Lenalidomide	Chronic myelogenous leukemia (Cell Line: K-562)	[2]
Lenalidomide + Picoplatin	DC9I9IH	Lenalidomide	Papillary renal cell carcinoma (Cell Line: ACHN)	[2]
Lenalidomide + Picoplatin	DCX61BE	Lenalidomide	Breast adenocarcinoma (Cell Line: MDA-MB-468)	[4]
Lenalidomide + Picoplatin	DCATFTA	Lenalidomide	Carcinoma (Cell Line: RXF 393)	[4]
Lenalidomide + Picoplatin	DCCB4UD	Lenalidomide	Colon adenocarcinoma (Cell Line: COLO 205)	[4]
Lenalidomide + Picoplatin	DCDIJSM	Lenalidomide	Adenocarcinoma (Cell Line: HT29)	[3]
Lenalidomide + Picoplatin	DCXT0DU	Lenalidomide	Adenocarcinoma (Cell Line: HCC-2998)	[3]
Lenalidomide + Picoplatin	DCLT4VL	Lenalidomide	Cutaneous melanoma (Cell Line: SK-MEL-28)	[3]
Lenalidomide + Picoplatin	DCEQKBK	Lenalidomide	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5)	[3]
Lenalidomide + Picoplatin	DCTMBN3	Lenalidomide	Lung adenocarcinoma (Cell Line: NCI-H522)	[3]
Lenalidomide + Picoplatin	DC2MICL	Lenalidomide	Melanoma (Cell Line: SK-MEL-2)	[3]
Lenalidomide + Picoplatin	DCLPCQR	Lenalidomide	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[3]
Maprotiline + Picoplatin	DCH5CYU	Maprotiline	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Mechlorethamine + Picoplatin	DCYCJI7	Mechlorethamine	Adult acute myeloid leukemia (Cell Line: HL-60(TB))	[2]
Mechlorethamine + Picoplatin	DCAG2ZB	Mechlorethamine	Astrocytoma (Cell Line: SNB-19)	[2]
Mechlorethamine + Picoplatin	DCCTUUE	Mechlorethamine	Clear cell renal cell carcinoma (Cell Line: 786-0)	[2]
Mechlorethamine + Picoplatin	DCMM7V0	Mechlorethamine	Glioma (Cell Line: SF-268)	[2]
Mechlorethamine + Picoplatin	DC9OYR3	Mechlorethamine	Breast adenocarcinoma (Cell Line: MDA-MB-468)	[4]
Mechlorethamine + Picoplatin	DC1LL3V	Mechlorethamine	Adenocarcinoma (Cell Line: HT29)	[3]
Mechlorethamine + Picoplatin	DC46DXK	Mechlorethamine	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5)	[3]
Mechlorethamine + Picoplatin	DC4KX7M	Mechlorethamine	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4)	[3]
Mechlorethamine + Picoplatin	DCC6MML	Mechlorethamine	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8)	[3]
Mechlorethamine + Picoplatin	DC2BUNW	Mechlorethamine	Lung adenocarcinoma (Cell Line: HOP-62)	[3]
Mechlorethamine + Picoplatin	DCQZ3UY	Mechlorethamine	Melanoma (Cell Line: SK-MEL-2)	[3]
Mechlorethamine + Picoplatin	DCGIBEJ	Mechlorethamine	Melanoma (Cell Line: UACC-257)	[3]
Mechlorethamine + Picoplatin	DC4GSHV	Mechlorethamine	Melanoma (Cell Line: MALME-3M)	[3]
Methocarbamol + Picoplatin	DCCJE61	Methocarbamol	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Methylene blue + Picoplatin	DCSEKPB	Methylene blue	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Metyrosine + Picoplatin	DC5Y6MJ	Metyrosine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Picoplatin + Aprepitant	DCM71OI	Aprepitant	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Picoplatin + Gefitinib	DC0GHA7	Gefitinib	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Picoplatin + Hepzato	DCLRTBY	Hepzato	Anaplastic large cell lymphoma (Cell Line: SR)	[2]
Picoplatin + Dactinomycin	DCW5EV8	Dactinomycin	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[2]
Picoplatin + Dactinomycin	DCZZLFC	Dactinomycin	Anaplastic large cell lymphoma (Cell Line: SR)	[2]
Picoplatin + Dactinomycin	DCOSZCO	Dactinomycin	Astrocytoma (Cell Line: U251)	[2]
Picoplatin + Dactinomycin	DCUU2BG	Dactinomycin	Astrocytoma (Cell Line: SNB-19)	[2]
Picoplatin + Dactinomycin	DCHNLIR	Dactinomycin	Chronic myelogenous leukemia (Cell Line: K-562)	[2]
Picoplatin + Dactinomycin	DC23F9K	Dactinomycin	Clear cell renal cell carcinoma (Cell Line: 786-0)	[2]
Picoplatin + Dactinomycin	DCCRE02	Dactinomycin	Clear cell renal cell carcinoma (Cell Line: TK-10)	[2]
Picoplatin + Dactinomycin	DCP6HF4	Dactinomycin	Clear cell renal cell carcinoma (Cell Line: CAKI-1)	[2]
Picoplatin + Dactinomycin	DC1AYM3	Dactinomycin	Glioblastoma (Cell Line: SNB-75)	[2]
Picoplatin + Dactinomycin	DCNW97Z	Dactinomycin	Glioma (Cell Line: SF-268)	[2]
Picoplatin + Dactinomycin	DCNF0EC	Dactinomycin	Glioma (Cell Line: SF-539)	[2]
Picoplatin + Dactinomycin	DCVCALY	Dactinomycin	Papillary renal cell carcinoma (Cell Line: ACHN)	[2]
Picoplatin + Dactinomycin	DCJRCE6	Dactinomycin	Plasma cell myeloma (Cell Line: RPMI-8226)	[2]
Picoplatin + Lapatinib	DCVXBTM	Lapatinib	Glioma (Cell Line: SF-268)	[2]
Picoplatin + Chlorphenesin	DCFPP4M	Chlorphenesin	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Picoplatin + Crizotinib	DCI8WCL	Crizotinib	Glioma (Cell Line: SF-295)	[2]
Picoplatin + Crizotinib	DCLWEKW	Crizotinib	Plasma cell myeloma (Cell Line: RPMI-8226)	[2]
Picoplatin + Cyclophosphamide	DCI9S2C	Cyclophosphamide	Astrocytoma (Cell Line: U251)	[2]
Picoplatin + Cyclophosphamide	DCJLIZ1	Cyclophosphamide	Clear cell renal cell carcinoma (Cell Line: CAKI-1)	[2]
Picoplatin + Isoniazid	DC7ESHP	Isoniazid	Astrocytoma (Cell Line: U251)	[2]
Picoplatin + Isoniazid	DC5X0MU	Isoniazid	Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)	[2]
Picoplatin + Isoniazid	DCC74TI	Isoniazid	Clear cell renal cell carcinoma (Cell Line: CAKI-1)	[2]
Picoplatin + Isoniazid	DCVXE2B	Isoniazid	Glioblastoma (Cell Line: SNB-75)	[2]
Picoplatin + Arsenic trioxide	DCWFV3R	Arsenic trioxide	Astrocytoma (Cell Line: SNB-19)	[2]
Picoplatin + Arsenic trioxide	DCECBAP	Arsenic trioxide	Glioblastoma (Cell Line: SNB-75)	[2]
Picoplatin + Arsenic trioxide	DC08QGV	Arsenic trioxide	Glioma (Cell Line: SF-295)	[2]
Picoplatin + Arsenic trioxide	DCTBULJ	Arsenic trioxide	Plasma cell myeloma (Cell Line: RPMI-8226)	[2]
Picoplatin + Vemurafenib	DCD0EN1	Vemurafenib	Chronic myelogenous leukemia (Cell Line: K-562)	[2]
Picoplatin + Vemurafenib	DCVJRQD	Vemurafenib	Glioma (Cell Line: SF-295)	[2]
Picoplatin + Vemurafenib	DC1OUAV	Vemurafenib	Glioma (Cell Line: SF-268)	[2]
Picoplatin + Vemurafenib	DCZPBLW	Vemurafenib	Renal cell carcinoma (Cell Line: SN12C)	[2]
Picoplatin + Plicamycin	DC6M03M	Plicamycin	Adult acute myeloid leukemia (Cell Line: HL-60(TB))	[2]
Picoplatin + Plicamycin	DC53QTP	Plicamycin	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[2]
Picoplatin + Plicamycin	DCQAGLB	Plicamycin	Clear cell renal cell carcinoma (Cell Line: TK-10)	[2]
Picoplatin + Plicamycin	DCJHH9Q	Plicamycin	Clear cell renal cell carcinoma (Cell Line: CAKI-1)	[2]
Picoplatin + Plicamycin	DC9U4H5	Plicamycin	Plasma cell myeloma (Cell Line: RPMI-8226)	[2]
Picoplatin + Nilotinib	DCYPID5	Nilotinib	Glioma (Cell Line: SF-268)	[2]
Picoplatin + Triapine	DC7B0LF	Triapine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Picoplatin + Triapine	DCIW6L0	Triapine	Glioblastoma (Cell Line: SNB-75)	[2]
Picoplatin + Topetecan	DCDHM2T	Topetecan	Glioma (Cell Line: SF-295)	[2]
Picoplatin + IT-141	DCGOHH1	IT-141	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Picoplatin + Pamidronate	DCE7ZE0	Pamidronate	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Picoplatin + Terameprocol	DCET8R2	Terameprocol	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[2]
Picoplatin + Terameprocol	DC78L8J	Terameprocol	Anaplastic large cell lymphoma (Cell Line: SR)	[2]
Picoplatin + Terameprocol	DCK58TP	Terameprocol	Astrocytoma (Cell Line: U251)	[2]
Picoplatin + Terameprocol	DC84PJ5	Terameprocol	Astrocytoma (Cell Line: SNB-19)	[2]
Picoplatin + Terameprocol	DCS640N	Terameprocol	Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)	[2]
Picoplatin + Terameprocol	DCAYZNM	Terameprocol	Clear cell renal cell carcinoma (Cell Line: CAKI-1)	[2]
Picoplatin + Terameprocol	DCTWTFF	Terameprocol	Glioblastoma (Cell Line: SNB-75)	[2]
Picoplatin + SCH 727965	DC9T9IU	SCH 727965	Glioma (Cell Line: SF-268)	[2]
Picoplatin + Itraconazole	DCE83Z6	Itraconazole	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Picoplatin + Ifosfamide	DCPIP5S	Ifosfamide	Plasma cell myeloma (Cell Line: RPMI-8226)	[2]
Picoplatin + Chlorzoxazone	DCBGDCF	Chlorzoxazone	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Picoplatin + Memantine	DCR8WJ5	Memantine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Picoplatin + Docetaxel	DC9MCRQ	Docetaxel	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Picoplatin + Raloxifene	DC75UHE	Raloxifene	Anaplastic large cell lymphoma (Cell Line: SR)	[2]
Picoplatin + Raloxifene	DC2REMC	Raloxifene	Clear cell renal cell carcinoma (Cell Line: A498)	[2]
Picoplatin + Pazopanib	DC4M2UO	Pazopanib	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Picoplatin + Mitomycin	DCUT0O8	Mitomycin	Adult acute myeloid leukemia (Cell Line: HL-60(TB))	[2]
Picoplatin + Pentamidine	DCZHTYU	Pentamidine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Picoplatin + Tolazoline	DC1HRDP	Tolazoline	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Picoplatin + Vincristine	DCZ51V3	Vincristine	Clear cell renal cell carcinoma (Cell Line: A498)	[2]
Picoplatin + Vincristine	DCZWP3D	Vincristine	Renal cell carcinoma (Cell Line: SN12C)	[2]
Picoplatin + Altretamine	DCK9OW7	Altretamine	Astrocytoma (Cell Line: SNB-19)	[2]
Picoplatin + Altretamine	DCAWMHB	Altretamine	Clear cell renal cell carcinoma (Cell Line: 786-0)	[2]
Picoplatin + Altretamine	DCO7VJ3	Altretamine	Papillary renal cell carcinoma (Cell Line: ACHN)	[2]
Picoplatin + Tiagabine	DCCLIA0	Tiagabine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Picoplatin + Fenoprofen	DCVOMH1	Fenoprofen	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Picoplatin + Idarubicin	DCEKTE2	Idarubicin	Astrocytoma (Cell Line: SNB-19)	[2]
Picoplatin + Idarubicin	DCXA09B	Idarubicin	Glioblastoma (Cell Line: SNB-75)	[2]
Picoplatin + Idarubicin	DCR5PN8	Idarubicin	Glioblastoma? (Cell Line: T98G)	[2]
Picoplatin + Idarubicin	DCX3TV5	Idarubicin	Glioma (Cell Line: SF-295)	[2]
Picoplatin + Idarubicin	DCXEOXT	Idarubicin	Renal cell carcinoma (Cell Line: SN12C)	[2]
Picoplatin + Imatinib	DC4IGC9	Imatinib	Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)	[2]
Picoplatin + Imatinib	DC6TG2I	Imatinib	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Picoplatin + Imatinib	DCTEOHU	Imatinib	Glioma (Cell Line: SF-268)	[2]
Picoplatin + Imatinib	DCMI3GJ	Imatinib	Renal cell carcinoma (Cell Line: UO-31)	[2]
Picoplatin + Imatinib	DCMWDVM	Imatinib	Renal cell carcinoma (Cell Line: SN12C)	[2]
Picoplatin + Abacavir	DCN1DBM	Abacavir	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Picoplatin + Bortezomib	DCTR4HZ	Bortezomib	Astrocytoma (Cell Line: U251)	[2]
Picoplatin + Bortezomib	DCOB0KV	Bortezomib	Astrocytoma (Cell Line: SNB-19)	[2]
Picoplatin + Bortezomib	DC6GYWM	Bortezomib	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Picoplatin + Bortezomib	DC9W9JD	Bortezomib	Glioblastoma (Cell Line: SNB-75)	[2]
Picoplatin + Eptifibatide	DC709NT	Eptifibatide	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Picoplatin + Cisplatin	DCUOFVP	Cisplatin	Adult acute myeloid leukemia (Cell Line: HL-60(TB))	[2]
Picoplatin + Cisplatin	DC50IM8	Cisplatin	Glioblastoma (Cell Line: SNB-75)	[2]
Picoplatin + Chlorambucil	DC8OJJG	Chlorambucil	Glioblastoma (Cell Line: SNB-75)	[2]
Picoplatin + ER819762	DC01GS5	ER819762	Glioma (Cell Line: SF-268)	[2]
Picoplatin + Romidepsin	DCD6SZ6	Romidepsin	Renal cell carcinoma (Cell Line: UO-31)	[2]
Picoplatin + Pomalidomide	DCIJ7RC	Pomalidomide	Astrocytoma (Cell Line: U251)	[2]
Picoplatin + Pomalidomide	DC1ZPM9	Pomalidomide	Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)	[2]
Picoplatin + Pomalidomide	DCKSW38	Pomalidomide	Clear cell renal cell carcinoma (Cell Line: 786-0)	[2]
Picoplatin + Pomalidomide	DC0KFPH	Pomalidomide	Clear cell renal cell carcinoma (Cell Line: CAKI-1)	[2]
Picoplatin + Pomalidomide	DCDGOP1	Pomalidomide	Glioblastoma (Cell Line: SNB-75)	[2]
Picoplatin + Pomalidomide	DC2FD0V	Pomalidomide	Glioma (Cell Line: SF-539)	[2]
Picoplatin + Pomalidomide	DCZ71RP	Pomalidomide	Glioma (Cell Line: SF-295)	[2]
Picoplatin + Pomalidomide	DCNPNEF	Pomalidomide	Renal cell carcinoma (Cell Line: SN12C)	[2]
Picoplatin + Mercaptopurine	DCQ0HJ6	Mercaptopurine	Glioblastoma (Cell Line: SNB-75)	[2]
Picoplatin + Mycophenolic acid	DCIRRFB	Mycophenolic acid	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Picoplatin + Mepacrine	DC3NCVL	Mepacrine	Renal cell carcinoma (Cell Line: UO-31)	[2]
Picoplatin + Mefloquine	DCDXB0F	Mefloquine	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Picoplatin + Zileuton	DCFJKXP	Zileuton	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Picoplatin + PMID28870136-Compound-43	DCK23YY	PMID28870136-Compound-43	Glioblastoma (Cell Line: SNB-75)	[2]
Picoplatin + PMID28870136-Compound-43	DCCY238	PMID28870136-Compound-43	Plasma cell myeloma (Cell Line: RPMI-8226)	[2]
Picoplatin + Cerivastatin	DCJREB3	Cerivastatin	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Picoplatin + Dasatinib	DCZ8EV2	Dasatinib	Anaplastic large cell lymphoma (Cell Line: SR)	[2]
Picoplatin + Cilostazol	DCDGB7C	Cilostazol	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Picoplatin + Dactinomycin	DCLS6IZ	Dactinomycin	Breast adenocarcinoma (Cell Line: MDA-MB-468)	[4]
Picoplatin + Dactinomycin	DCEQ9HP	Dactinomycin	Carcinoma (Cell Line: RXF 393)	[4]
Picoplatin + Dactinomycin	DCUM2FV	Dactinomycin	Carcinoma (Cell Line: MCF7)	[4]
Picoplatin + Dactinomycin	DC5UQ23	Dactinomycin	Colon adenocarcinoma (Cell Line: COLO 205)	[4]
Picoplatin + Dactinomycin	DC56C4Q	Dactinomycin	Invasive ductal carcinoma (Cell Line: BT-549)	[4]
Picoplatin + Dactinomycin	DCMOVO8	Dactinomycin	Invasive ductal carcinoma (Cell Line: T-47D)	[4]
Picoplatin + Dactinomycin	DC8Y1IU	Dactinomycin	Invasive ductal carcinoma (Cell Line: HS 578T)	[4]
Picoplatin + DFN-15	DCD3GLE	DFN-15	Colon carcinoma (Cell Line: KM12)	[4]
Picoplatin + PMID28460551-Compound-2	DCKGTFE	PMID28460551-Compound-2	Colon carcinoma (Cell Line: KM12)	[4]
Picoplatin + Crizotinib	DCSB0VS	Crizotinib	Invasive ductal carcinoma (Cell Line: BT-549)	[4]
Picoplatin + Isoniazid	DCC3OKL	Isoniazid	Colon carcinoma (Cell Line: KM12)	[4]
Picoplatin + Plicamycin	DCL9DJ7	Plicamycin	Breast adenocarcinoma (Cell Line: MDA-MB-468)	[4]
Picoplatin + Plicamycin	DC9VOU3	Plicamycin	Carcinoma (Cell Line: RXF 393)	[4]
Picoplatin + Plicamycin	DCJHSDT	Plicamycin	Colon carcinoma (Cell Line: KM12)	[4]
Picoplatin + Plicamycin	DCCJY7Y	Plicamycin	Invasive ductal carcinoma (Cell Line: BT-549)	[4]
Picoplatin + Plicamycin	DC1HP05	Plicamycin	Invasive ductal carcinoma (Cell Line: T-47D)	[4]
Picoplatin + Plicamycin	DCGGMYY	Plicamycin	Invasive ductal carcinoma (Cell Line: HS 578T)	[4]
Picoplatin + Terameprocol	DCA9WTM	Terameprocol	Colon carcinoma (Cell Line: KM12)	[4]
Picoplatin + SCH 727965	DCV2428	SCH 727965	Carcinoma (Cell Line: RXF 393)	[4]
Picoplatin + SCH 727965	DCFP548	SCH 727965	Colon adenocarcinoma (Cell Line: COLO 205)	[4]
Picoplatin + Ifosfamide	DC3R2ND	Ifosfamide	Carcinoma (Cell Line: RXF 393)	[4]
Picoplatin + Letrozole	DC6KRY1	Letrozole	Invasive ductal carcinoma (Cell Line: T-47D)	[4]
Picoplatin + Mitomycin	DCTXP4B	Mitomycin	Carcinoma (Cell Line: RXF 393)	[4]
Picoplatin + Mitomycin	DC5XI9G	Mitomycin	Colon carcinoma (Cell Line: KM12)	[4]
Picoplatin + SY-1425	DCUQD9C	SY-1425	Colon carcinoma (Cell Line: KM12)	[4]
Picoplatin + Altretamine	DCO1OFG	Altretamine	Carcinoma (Cell Line: RXF 393)	[4]
Picoplatin + Altretamine	DC6SBUM	Altretamine	Colon carcinoma (Cell Line: KM12)	[4]
Picoplatin + Altretamine	DCV4OQB	Altretamine	Invasive ductal carcinoma (Cell Line: HS 578T)	[4]
Picoplatin + Bleomycin	DC92JF2	Bleomycin	Carcinoma (Cell Line: MCF7)	[4]
Picoplatin + Bortezomib	DCGKAGZ	Bortezomib	Colon adenocarcinoma (Cell Line: COLO 205)	[4]
Picoplatin + Valrubicin	DCDUSIR	Valrubicin	Colon adenocarcinoma (Cell Line: COLO 205)	[4]
Picoplatin + Pomalidomide	DC9OD1Y	Pomalidomide	Colon carcinoma (Cell Line: KM12)	[4]
Picoplatin + Mercaptopurine	DCBV4IS	Mercaptopurine	Invasive ductal carcinoma (Cell Line: HS 578T)	[4]
Picoplatin + Mepacrine	DCMKCNU	Mepacrine	Colon carcinoma (Cell Line: KM12)	[4]
Picoplatin + PMID28870136-Compound-43	DCQZXRE	PMID28870136-Compound-43	Invasive ductal carcinoma (Cell Line: HS 578T)	[4]
Picoplatin + PMID28870136-Compound-43	DC5RRUJ	PMID28870136-Compound-43	Invasive ductal carcinoma (Cell Line: BT-549)	[4]
Picoplatin + FORMESTANE	DCZAIUK	FORMESTANE	Colon carcinoma (Cell Line: KM12)	[4]
Picoplatin + Hepzato	DCNJ472	Hepzato	Lung adenocarcinoma (Cell Line: HOP-62)	[3]
Picoplatin + Ixabepilone	DCOKANG	Ixabepilone	Adenocarcinoma (Cell Line: NCIH23)	[3]
Picoplatin + Ixabepilone	DC32TH9	Ixabepilone	Adenocarcinoma (Cell Line: HCT-15)	[3]
Picoplatin + Ixabepilone	DCD6H56	Ixabepilone	Non-small cell lung carcinoma (Cell Line: HOP-92)	[3]
Picoplatin + Ixabepilone	DCGKM2M	Ixabepilone	Prostate carcinoma (Cell Line: PC-3)	[3]
Picoplatin + Dactinomycin	DC6M62L	Dactinomycin	Adenocarcinoma (Cell Line: OVCAR3)	[3]
Picoplatin + Dactinomycin	DCAKE5Q	Dactinomycin	Adenocarcinoma (Cell Line: NCIH23)	[3]
Picoplatin + Dactinomycin	DC1ZRKV	Dactinomycin	Adenocarcinoma (Cell Line: HCT116)	[3]
Picoplatin + Dactinomycin	DCLW8XW	Dactinomycin	Adenocarcinoma (Cell Line: HCC-2998)	[3]
Picoplatin + Dactinomycin	DCTCZRS	Dactinomycin	Adenocarcinoma (Cell Line: SW-620)	[3]
Picoplatin + Dactinomycin	DCWQB6D	Dactinomycin	Cutaneous melanoma (Cell Line: SK-MEL-28)	[3]
Picoplatin + Dactinomycin	DC9CMZZ	Dactinomycin	Cutaneous melanoma (Cell Line: SK-MEL-5)	[3]
Picoplatin + Dactinomycin	DCXGF5K	Dactinomycin	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4)	[3]
Picoplatin + Dactinomycin	DCR7VTS	Dactinomycin	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8)	[3]
Picoplatin + Dactinomycin	DCC0BXJ	Dactinomycin	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5)	[3]
Picoplatin + Dactinomycin	DC0MQOM	Dactinomycin	Large cell lung carcinoma (Cell Line: NCI-H460)	[3]
Picoplatin + Dactinomycin	DCRO1QE	Dactinomycin	Lung adenocarcinoma (Cell Line: EKVX)	[3]
Picoplatin + Dactinomycin	DCH59RS	Dactinomycin	Lung adenocarcinoma (Cell Line: HOP-62)	[3]
Picoplatin + Dactinomycin	DCY85D5	Dactinomycin	Lung adenocarcinoma (Cell Line: MDA-MB-231)	[3]
Picoplatin + Dactinomycin	DCDBOV0	Dactinomycin	Lung adenocarcinoma (Cell Line: NCI-H522)	[3]
Picoplatin + Dactinomycin	DCGP60J	Dactinomycin	Malignant melanoma (Cell Line: LOX IMVI)	[3]
Picoplatin + Dactinomycin	DCO3MBC	Dactinomycin	Malignant melanoma (Cell Line: UACC62)	[3]
Picoplatin + Dactinomycin	DC9GYP9	Dactinomycin	Melanoma (Cell Line: MALME-3M)	[3]
Picoplatin + Dactinomycin	DCR1N4B	Dactinomycin	Melanoma (Cell Line: UACC-257)	[3]
Picoplatin + Dactinomycin	DCHAYHO	Dactinomycin	Melanoma (Cell Line: SK-MEL-2)	[3]
Picoplatin + Dactinomycin	DC51IYF	Dactinomycin	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[3]
Picoplatin + Dactinomycin	DCNC0G8	Dactinomycin	Non-small cell lung carcinoma (Cell Line: HOP-92)	[3]
Picoplatin + Dactinomycin	DCG6KWX	Dactinomycin	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[3]
Picoplatin + Dactinomycin	DCYDXGA	Dactinomycin	Pleural epithelioid mesothelioma (Cell Line: NCI-H226)	[3]
Picoplatin + DFN-15	DCTGZ41	DFN-15	Large cell lung carcinoma (Cell Line: NCI-H460)	[3]
Picoplatin + Lapatinib	DCUBD3C	Lapatinib	Adenocarcinoma (Cell Line: NCIH23)	[3]
Picoplatin + Lapatinib	DCSP3XK	Lapatinib	Adenocarcinoma (Cell Line: HT29)	[3]
Picoplatin + Lapatinib	DCNQDVP	Lapatinib	Amelanotic melanoma (Cell Line: MDA-MB-435)	[3]
Picoplatin + Lapatinib	DCDL04R	Lapatinib	Amelanotic melanoma (Cell Line: M14)	[3]
Picoplatin + Lapatinib	DCM72ID	Lapatinib	Cutaneous melanoma (Cell Line: SK-MEL-28)	[3]
Picoplatin + Lapatinib	DC4CYLK	Lapatinib	Lung adenocarcinoma (Cell Line: HOP-62)	[3]
Picoplatin + PMID28460551-Compound-2	DCE3AOX	PMID28460551-Compound-2	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[3]
Picoplatin + Crizotinib	DCPFGPH	Crizotinib	Lung adenocarcinoma (Cell Line: HOP-62)	[3]
Picoplatin + Crizotinib	DC0JB3A	Crizotinib	Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)	[3]
Picoplatin + Cyclophosphamide	DC1N6ZE	Cyclophosphamide	High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)	[3]
Picoplatin + LIAROZOLE	DC17OXT	LIAROZOLE	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[3]
Picoplatin + LIAROZOLE	DC2Y6NQ	LIAROZOLE	Pleural epithelioid mesothelioma (Cell Line: NCI-H226)	[3]
Picoplatin + Methotrexate	DCRR2TN	Methotrexate	Lung adenocarcinoma (Cell Line: MDA-MB-231)	[3]
Picoplatin + Methotrexate	DC1U53U	Methotrexate	Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)	[3]
Picoplatin + Methotrexate	DCGKUYA	Methotrexate	Pleural epithelioid mesothelioma (Cell Line: NCI-H226)	[3]
Picoplatin + Isoniazid	DCNXCJL	Isoniazid	High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)	[3]
Picoplatin + Isoniazid	DC9P4L2	Isoniazid	Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)	[3]
Picoplatin + Isoniazid	DC8HXMK	Isoniazid	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[3]
Picoplatin + Isoniazid	DC4GUNG	Isoniazid	Non-small cell lung carcinoma (Cell Line: HOP-92)	[3]
Picoplatin + Isoniazid	DCEMKB3	Isoniazid	Pleural epithelioid mesothelioma (Cell Line: NCI-H226)	[3]
Picoplatin + Arsenic trioxide	DC25N5H	Arsenic trioxide	Adenocarcinoma (Cell Line: DU-145)	[3]
Picoplatin + Arsenic trioxide	DCIHX1F	Arsenic trioxide	Amelanotic melanoma (Cell Line: MDA-MB-435)	[3]
Picoplatin + Arsenic trioxide	DCYR6CU	Arsenic trioxide	Amelanotic melanoma (Cell Line: M14)	[3]
Picoplatin + Arsenic trioxide	DCG8NCE	Arsenic trioxide	Cutaneous melanoma (Cell Line: SK-MEL-28)	[3]
Picoplatin + Arsenic trioxide	DCB538R	Arsenic trioxide	Malignant melanoma (Cell Line: UACC62)	[3]
Picoplatin + Arsenic trioxide	DC9191G	Arsenic trioxide	Melanoma (Cell Line: UACC-257)	[3]
Picoplatin + Vemurafenib	DCQSXAM	Vemurafenib	Adenocarcinoma (Cell Line: DU-145)	[3]
Picoplatin + Vemurafenib	DCX4UTX	Vemurafenib	Adenocarcinoma (Cell Line: NCIH23)	[3]
Picoplatin + Vemurafenib	DC16W9R	Vemurafenib	Adenocarcinoma (Cell Line: HCT116)	[3]
Picoplatin + Vemurafenib	DCR423I	Vemurafenib	Adenocarcinoma (Cell Line: HCT-15)	[3]
Picoplatin + Vemurafenib	DCAEBFF	Vemurafenib	Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)	[3]
Picoplatin + Vemurafenib	DCHRUWV	Vemurafenib	Prostate carcinoma (Cell Line: PC-3)	[3]
Picoplatin + Plicamycin	DCTUAWX	Plicamycin	Cutaneous melanoma (Cell Line: SK-MEL-5)	[3]
Picoplatin + Plicamycin	DCM9JS5	Plicamycin	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4)	[3]
Picoplatin + Plicamycin	DC5PE0N	Plicamycin	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5)	[3]
Picoplatin + Plicamycin	DCWUXXB	Plicamycin	High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)	[3]
Picoplatin + Plicamycin	DCCDCJ4	Plicamycin	Lung adenocarcinoma (Cell Line: MDA-MB-231)	[3]
Picoplatin + Plicamycin	DCGJ8U1	Plicamycin	Lung adenocarcinoma (Cell Line: NCI-H522)	[3]
Picoplatin + Plicamycin	DC624CF	Plicamycin	Malignant melanoma (Cell Line: UACC62)	[3]
Picoplatin + Plicamycin	DCOUT8S	Plicamycin	Melanoma (Cell Line: MALME-3M)	[3]
Picoplatin + Plicamycin	DCK5TKT	Plicamycin	Melanoma (Cell Line: UACC-257)	[3]
Picoplatin + Plicamycin	DCCYYQB	Plicamycin	Melanoma (Cell Line: SK-MEL-2)	[3]
Picoplatin + Plicamycin	DCB85J3	Plicamycin	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[3]
Picoplatin + Nilotinib	DC4JSYO	Nilotinib	Adenocarcinoma (Cell Line: A549)	[3]
Picoplatin + Nilotinib	DCVUP12	Nilotinib	Adenocarcinoma (Cell Line: NCIH23)	[3]
Picoplatin + Nilotinib	DCBW7SB	Nilotinib	Adenocarcinoma (Cell Line: HCT116)	[3]
Picoplatin + Nilotinib	DCCUKQ2	Nilotinib	Adenocarcinoma (Cell Line: HCT-15)	[3]
Picoplatin + Nilotinib	DCQTPUP	Nilotinib	Cutaneous melanoma (Cell Line: SK-MEL-28)	[3]
Picoplatin + Nilotinib	DC2F68Y	Nilotinib	Lung adenocarcinoma (Cell Line: HOP-62)	[3]
Picoplatin + Nilotinib	DCXCL3G	Nilotinib	Melanoma (Cell Line: SK-MEL-2)	[3]
Picoplatin + Topetecan	DCZ132G	Topetecan	Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)	[3]
Picoplatin + Pralatrexate	DC7LUCW	Pralatrexate	Adenocarcinoma (Cell Line: A549)	[3]
Picoplatin + Pralatrexate	DC8F6TI	Pralatrexate	Adenocarcinoma (Cell Line: NCIH23)	[3]
Picoplatin + Pralatrexate	DC2DJEG	Pralatrexate	Adenocarcinoma (Cell Line: HCT-15)	[3]
Picoplatin + Pralatrexate	DCL9YUA	Pralatrexate	Adenocarcinoma (Cell Line: HCC-2998)	[3]
Picoplatin + Pralatrexate	DC693S8	Pralatrexate	Large cell lung carcinoma (Cell Line: NCI-H460)	[3]
Picoplatin + Pralatrexate	DCYB8EO	Pralatrexate	Lung adenocarcinoma (Cell Line: HOP-62)	[3]
Picoplatin + Pralatrexate	DC4KVYE	Pralatrexate	Lung adenocarcinoma (Cell Line: MDA-MB-231)	[3]
Picoplatin + Terameprocol	DC06LX9	Terameprocol	Adenocarcinoma (Cell Line: HT29)	[3]
Picoplatin + Terameprocol	DC8HATX	Terameprocol	Adenocarcinoma (Cell Line: HCT-15)	[3]
Picoplatin + Terameprocol	DCSNOBC	Terameprocol	High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)	[3]
Picoplatin + Terameprocol	DCL4GX3	Terameprocol	Lung adenocarcinoma (Cell Line: NCI-H522)	[3]
Picoplatin + Terameprocol	DC7V87N	Terameprocol	Malignant melanoma (Cell Line: UACC62)	[3]
Picoplatin + Terameprocol	DCSZ3FB	Terameprocol	Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)	[3]
Picoplatin + Terameprocol	DCOCPP3	Terameprocol	Pleural epithelioid mesothelioma (Cell Line: NCI-H226)	[3]
Picoplatin + SCH 727965	DCCZVZ5	SCH 727965	Adenocarcinoma (Cell Line: A549)	[3]
Picoplatin + SCH 727965	DCC1NRT	SCH 727965	Adenocarcinoma (Cell Line: NCIH23)	[3]
Picoplatin + SCH 727965	DC720PE	SCH 727965	Cutaneous melanoma (Cell Line: SK-MEL-5)	[3]
Picoplatin + SCH 727965	DCR2ESQ	SCH 727965	Large cell lung carcinoma (Cell Line: NCI-H460)	[3]
Picoplatin + SCH 727965	DCSP3L4	SCH 727965	Lung adenocarcinoma (Cell Line: MDA-MB-231)	[3]
Picoplatin + SCH 727965	DC5N9FC	SCH 727965	Lung adenocarcinoma (Cell Line: HOP-62)	[3]
Picoplatin + Ifosfamide	DCNJD3T	Ifosfamide	High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)	[3]
Picoplatin + Ifosfamide	DCUV9BR	Ifosfamide	Lung adenocarcinoma (Cell Line: MDA-MB-231)	[3]
Picoplatin + Raloxifene	DC1I9XN	Raloxifene	Lung adenocarcinoma (Cell Line: HOP-62)	[3]
Picoplatin + Raloxifene	DCAJ4I8	Raloxifene	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[3]
Picoplatin + Raloxifene	DCNEOM9	Raloxifene	Pleural epithelioid mesothelioma (Cell Line: NCI-H226)	[3]
Picoplatin + Bendamustine hydrochloride	DCIN20I	Bendamustine hydrochloride	Large cell lung carcinoma (Cell Line: NCI-H460)	[3]
Picoplatin + Bendamustine hydrochloride	DCDKYNK	Bendamustine hydrochloride	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[3]
Picoplatin + Letrozole	DC2K7ZN	Letrozole	Large cell lung carcinoma (Cell Line: NCI-H460)	[3]
Picoplatin + Letrozole	DCJEUQ9	Letrozole	Prostate carcinoma (Cell Line: PC-3)	[3]
Picoplatin + Mitomycin	DCDSF4J	Mitomycin	Amelanotic melanoma (Cell Line: M14)	[3]
Picoplatin + Mitomycin	DCKT9YT	Mitomycin	High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)	[3]
Picoplatin + Mitomycin	DCTC2RS	Mitomycin	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[3]
Picoplatin + Mitomycin	DCHYBMQ	Mitomycin	Non-small cell lung carcinoma (Cell Line: HOP-92)	[3]
Picoplatin + SY-1425	DCLIWEX	SY-1425	Adenocarcinoma (Cell Line: HT29)	[3]
Picoplatin + SY-1425	DCSARLZ	SY-1425	Cutaneous melanoma (Cell Line: SK-MEL-28)	[3]
Picoplatin + SY-1425	DC9ZSYU	SY-1425	Melanoma (Cell Line: SK-MEL-2)	[3]
Picoplatin + SY-1425	DC4CTNN	SY-1425	Non-small cell lung carcinoma (Cell Line: HOP-92)	[3]
Picoplatin + SY-1425	DCOUEIR	SY-1425	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[3]
Picoplatin + Vincristine	DCF8N8W	Vincristine	Large cell lung carcinoma (Cell Line: NCI-H460)	[3]
Picoplatin + Arfolitixorin	DC6SABW	Arfolitixorin	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4)	[3]
Picoplatin + Arfolitixorin	DC4KZR8	Arfolitixorin	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[3]
Picoplatin + Altretamine	DC6VC4X	Altretamine	Adenocarcinoma (Cell Line: HT29)	[3]
Picoplatin + Altretamine	DCKH8ME	Altretamine	Amelanotic melanoma (Cell Line: M14)	[3]
Picoplatin + Altretamine	DCVMQB8	Altretamine	Cutaneous melanoma (Cell Line: SK-MEL-28)	[3]
Picoplatin + Altretamine	DC96QT0	Altretamine	Cutaneous melanoma (Cell Line: SK-MEL-5)	[3]
Picoplatin + Altretamine	DCYH84J	Altretamine	High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)	[3]
Picoplatin + Altretamine	DC956K3	Altretamine	Lung adenocarcinoma (Cell Line: MDA-MB-231)	[3]
Picoplatin + Altretamine	DCP0EUQ	Altretamine	Malignant melanoma (Cell Line: UACC62)	[3]
Picoplatin + Altretamine	DCYXGCE	Altretamine	Melanoma (Cell Line: SK-MEL-2)	[3]
Picoplatin + Altretamine	DC7IGR3	Altretamine	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[3]
Picoplatin + TEM	DC0898C	TEM	Adenocarcinoma (Cell Line: DU-145)	[3]
Picoplatin + TEM	DCVY6C4	TEM	Adenocarcinoma (Cell Line: HCT116)	[3]
Picoplatin + TEM	DCG8LNV	TEM	Large cell lung carcinoma (Cell Line: NCI-H460)	[3]
Picoplatin + TEM	DCTBUB2	TEM	Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)	[3]
Picoplatin + TEM	DCN37EB	TEM	Prostate carcinoma (Cell Line: PC-3)	[3]
Picoplatin + Idarubicin	DCLC14G	Idarubicin	Adenocarcinoma (Cell Line: NCIH23)	[3]
Picoplatin + Idarubicin	DCFADXK	Idarubicin	Adenocarcinoma (Cell Line: HCT-15)	[3]
Picoplatin + Idarubicin	DCRIPRT	Idarubicin	Adenocarcinoma (Cell Line: HT29)	[3]
Picoplatin + Idarubicin	DC283XI	Idarubicin	Cutaneous melanoma (Cell Line: SK-MEL-5)	[3]
Picoplatin + Idarubicin	DCLWFWN	Idarubicin	Cutaneous melanoma (Cell Line: SK-MEL-28)	[3]
Picoplatin + Idarubicin	DC0CNKO	Idarubicin	Lung adenocarcinoma (Cell Line: HOP-62)	[3]
Picoplatin + Idarubicin	DC40G82	Idarubicin	Melanoma (Cell Line: MALME-3M)	[3]
Picoplatin + Idarubicin	DC0WOVR	Idarubicin	Pleural epithelioid mesothelioma (Cell Line: NCI-H226)	[3]
Picoplatin + Idarubicin	DCJI9IV	Idarubicin	Prostate carcinoma (Cell Line: PC-3)	[3]
Picoplatin + Imatinib	DCXV09H	Imatinib	Adenocarcinoma (Cell Line: HCT116)	[3]
Picoplatin + Imatinib	DC12QCA	Imatinib	Amelanotic melanoma (Cell Line: MDA-MB-435)	[3]
Picoplatin + Imatinib	DCZQCOY	Imatinib	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8)	[3]
Picoplatin + Imatinib	DCDPG1W	Imatinib	Large cell lung carcinoma (Cell Line: NCI-H460)	[3]
Picoplatin + Imatinib	DCF48G5	Imatinib	Malignant melanoma (Cell Line: LOX IMVI)	[3]
Picoplatin + Imatinib	DCVK28V	Imatinib	Melanoma (Cell Line: SK-MEL-2)	[3]
Picoplatin + Imatinib	DCAIS0Y	Imatinib	Pleural epithelioid mesothelioma (Cell Line: NCI-H226)	[3]
Picoplatin + Imatinib	DCBIPJN	Imatinib	Prostate carcinoma (Cell Line: PC-3)	[3]
Picoplatin + Bleomycin	DCIJ03W	Bleomycin	Melanoma (Cell Line: SK-MEL-2)	[3]
Picoplatin + Bortezomib	DCA78QD	Bortezomib	Adenocarcinoma (Cell Line: NCIH23)	[3]
Picoplatin + Bortezomib	DCIGGUE	Bortezomib	Adenocarcinoma (Cell Line: A549)	[3]
Picoplatin + Bortezomib	DCES19B	Bortezomib	Adenocarcinoma (Cell Line: HCT-15)	[3]
Picoplatin + Bortezomib	DCHF2EG	Bortezomib	Adenocarcinoma (Cell Line: HCT116)	[3]
Picoplatin + Bortezomib	DCQLIRL	Bortezomib	Lung adenocarcinoma (Cell Line: HOP-62)	[3]
Picoplatin + Bortezomib	DC1XI6L	Bortezomib	Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)	[3]
Picoplatin + Bortezomib	DCWL1MF	Bortezomib	Pleural epithelioid mesothelioma (Cell Line: NCI-H226)	[3]
Picoplatin + Cisplatin	DC416PV	Cisplatin	Adenocarcinoma (Cell Line: A549)	[3]
Picoplatin + Cisplatin	DC6UNMO	Cisplatin	Amelanotic melanoma (Cell Line: M14)	[3]
Picoplatin + Cisplatin	DC91C3A	Cisplatin	Cutaneous melanoma (Cell Line: SK-MEL-28)	[3]
Picoplatin + Cisplatin	DCI0TJQ	Cisplatin	High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)	[3]
Picoplatin + Cisplatin	DCBGGAO	Cisplatin	Melanoma (Cell Line: SK-MEL-2)	[3]
Picoplatin + Cisplatin	DCJ9C67	Cisplatin	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[3]
Picoplatin + Cisplatin	DC0NJI9	Cisplatin	Non-small cell lung carcinoma (Cell Line: HOP-92)	[3]
Picoplatin + Cisplatin	DCSIK94	Cisplatin	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[3]
Picoplatin + Chlorambucil	DC4NIDK	Chlorambucil	Adenocarcinoma (Cell Line: DU-145)	[3]
Picoplatin + Chlorambucil	DCHYQ41	Chlorambucil	Adenocarcinoma (Cell Line: HT29)	[3]
Picoplatin + Chlorambucil	DCSJHG6	Chlorambucil	Amelanotic melanoma (Cell Line: MDA-MB-435)	[3]
Picoplatin + Chlorambucil	DC4HK60	Chlorambucil	Lung adenocarcinoma (Cell Line: HOP-62)	[3]
Picoplatin + Chlorambucil	DCF36ES	Chlorambucil	Melanoma (Cell Line: SK-MEL-2)	[3]
Picoplatin + Chlorambucil	DCJAVM4	Chlorambucil	Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)	[3]
Picoplatin + ER819762	DCT728J	ER819762	Adenocarcinoma (Cell Line: OVCAR3)	[3]
Picoplatin + ER819762	DC0DRA3	ER819762	Adenocarcinoma (Cell Line: NCIH23)	[3]
Picoplatin + ER819762	DC6UT62	ER819762	Adenocarcinoma (Cell Line: HCT-15)	[3]
Picoplatin + ER819762	DCPTV8N	ER819762	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4)	[3]
Picoplatin + ER819762	DCKU36B	ER819762	Lung adenocarcinoma (Cell Line: HOP-62)	[3]
Picoplatin + ER819762	DCPYCTU	ER819762	Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)	[3]
Picoplatin + ER819762	DCIKLYZ	ER819762	Prostate carcinoma (Cell Line: PC-3)	[3]
Picoplatin + Azacitidine	DCU0F3W	Azacitidine	Cutaneous melanoma (Cell Line: SK-MEL-28)	[3]
Picoplatin + Azacitidine	DCF432A	Azacitidine	Malignant melanoma (Cell Line: UACC62)	[3]
Picoplatin + Pomalidomide	DC4RO2Q	Pomalidomide	Adenocarcinoma (Cell Line: OVCAR3)	[3]
Picoplatin + Pomalidomide	DCKIOHH	Pomalidomide	Adenocarcinoma (Cell Line: NCIH23)	[3]
Picoplatin + Pomalidomide	DCX9MAV	Pomalidomide	Adenocarcinoma (Cell Line: HCT116)	[3]
Picoplatin + Pomalidomide	DCKKTIO	Pomalidomide	Adenocarcinoma (Cell Line: HT29)	[3]
Picoplatin + Pomalidomide	DC9HBXB	Pomalidomide	Amelanotic melanoma (Cell Line: M14)	[3]
Picoplatin + Pomalidomide	DCX110E	Pomalidomide	Amelanotic melanoma (Cell Line: MDA-MB-435)	[3]
Picoplatin + Pomalidomide	DCMC1M7	Pomalidomide	High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)	[3]
Picoplatin + Pomalidomide	DCZHC1T	Pomalidomide	Lung adenocarcinoma (Cell Line: EKVX)	[3]
Picoplatin + Pomalidomide	DCBTK9L	Pomalidomide	Lung adenocarcinoma (Cell Line: NCI-H522)	[3]
Picoplatin + Pomalidomide	DCD72RJ	Pomalidomide	Malignant melanoma (Cell Line: UACC62)	[3]
Picoplatin + Pomalidomide	DCK1I2O	Pomalidomide	Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)	[3]
Picoplatin + Pomalidomide	DCZ2YL3	Pomalidomide	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[3]
Picoplatin + Pomalidomide	DCENK0E	Pomalidomide	Non-small cell lung carcinoma (Cell Line: HOP-92)	[3]
Picoplatin + Pomalidomide	DCDY8F1	Pomalidomide	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[3]
Picoplatin + Pomalidomide	DC40SUG	Pomalidomide	Pleural epithelioid mesothelioma (Cell Line: NCI-H226)	[3]
Picoplatin + Mercaptopurine	DCP1F07	Mercaptopurine	Amelanotic melanoma (Cell Line: M14)	[3]
Picoplatin + Mercaptopurine	DCIDCIW	Mercaptopurine	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[3]
Picoplatin + Mepacrine	DCRBW3J	Mepacrine	Amelanotic melanoma (Cell Line: MDA-MB-435)	[3]
Picoplatin + Mepacrine	DCXZ7JE	Mepacrine	High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)	[3]
Picoplatin + Mepacrine	DC6V5TV	Mepacrine	Malignant melanoma (Cell Line: UACC62)	[3]
Picoplatin + Mepacrine	DCTR5FC	Mepacrine	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[3]
Picoplatin + PMID28870136-Compound-43	DC3OTNN	PMID28870136-Compound-43	Adenocarcinoma (Cell Line: HCC-2998)	[3]
Picoplatin + PMID28870136-Compound-43	DCF3H6N	PMID28870136-Compound-43	Adenocarcinoma (Cell Line: HT29)	[3]
Picoplatin + PMID28870136-Compound-43	DCZKQ6D	PMID28870136-Compound-43	Amelanotic melanoma (Cell Line: M14)	[3]
Picoplatin + PMID28870136-Compound-43	DCKLUM4	PMID28870136-Compound-43	Cutaneous melanoma (Cell Line: SK-MEL-5)	[3]
Picoplatin + PMID28870136-Compound-43	DC6NKK8	PMID28870136-Compound-43	Cutaneous melanoma (Cell Line: SK-MEL-28)	[3]
Picoplatin + PMID28870136-Compound-43	DCTZYIH	PMID28870136-Compound-43	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5)	[3]
Picoplatin + PMID28870136-Compound-43	DC6D82M	PMID28870136-Compound-43	High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)	[3]
Picoplatin + PMID28870136-Compound-43	DCUBEL0	PMID28870136-Compound-43	Malignant melanoma (Cell Line: LOX IMVI)	[3]
Picoplatin + PMID28870136-Compound-43	DCSTD5I	PMID28870136-Compound-43	Non-small cell lung carcinoma (Cell Line: HOP-92)	[3]
Picoplatin + PMID28870136-Compound-43	DCAQ091	PMID28870136-Compound-43	Pleural epithelioid mesothelioma (Cell Line: NCI-H226)	[3]
Picoplatin + FORMESTANE	DCJK7CA	FORMESTANE	Prostate carcinoma (Cell Line: PC-3)	[3]
Picoplatin + Estramustine	DCJSWMU	Estramustine	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[3]
Picoplatin + Busulfan	DC69D64	Busulfan	Amelanotic melanoma (Cell Line: M14)	[3]
Picoplatin + Busulfan	DC00P7P	Busulfan	Cutaneous melanoma (Cell Line: SK-MEL-28)	[3]
Picoplatin + Busulfan	DCYVD5V	Busulfan	High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)	[3]
Picoplatin + Busulfan	DCXXZBO	Busulfan	Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)	[3]
Picoplatin + Busulfan	DC7NCXD	Busulfan	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[3]
Picoplatin + Dasatinib	DCX2HND	Dasatinib	Amelanotic melanoma (Cell Line: MDA-MB-435)	[3]
Pyrazinamide + Picoplatin	DCV2V9S	Pyrazinamide	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Raloxifene + Picoplatin	DCABBO2	Raloxifene	Adenocarcinoma (Cell Line: DU-145)	[3]
Ruxolitinib + Picoplatin	DCJ48VL	Ruxolitinib	Invasive ductal carcinoma (Cell Line: T-47D)	[4]
Ruxolitinib + Picoplatin	DC4121G	Ruxolitinib	Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)	[3]
Testosterone cypionate + Picoplatin	DCY0AE7	Testosterone cypionate	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
Thioguanine + Picoplatin	DCKQO06	Thioguanine	Anaplastic large cell lymphoma (Cell Line: SR)	[2]
Thioguanine + Picoplatin	DC98CXA	Thioguanine	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[3]
Topotecan + Picoplatin	DCHBDZ4	Topotecan	Clear cell renal cell carcinoma (Cell Line: CAKI-1)	[3]
Topotecan + Picoplatin	DCEPOLH	Topotecan	Glioblastoma (Cell Line: SNB-75)	[3]
Topotecan + Picoplatin	DCAQEQW	Topotecan	Glioma (Cell Line: SF-268)	[3]
Topotecan + Picoplatin	DCZN7EW	Topotecan	Lung adenocarcinoma (Cell Line: EKVX)	[3]
Topotecan + Picoplatin	DCUPNPP	Topotecan	Melanoma (Cell Line: UACC-257)	[3]
Topotecan + Picoplatin	DCHQ8IZ	Topotecan	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[3]
Uracil mustard + Picoplatin	DCOCD0V	Uracil mustard	Anaplastic large cell lymphoma (Cell Line: SR)	[2]
Vemurafenib + Picoplatin	DC8GDBR	Vemurafenib	Adenocarcinoma (Cell Line: DU-145)	[3]
Vemurafenib + Picoplatin	DC8NCOE	Vemurafenib	Lung adenocarcinoma (Cell Line: NCI-H522)	[3]
Vemurafenib + Picoplatin	DCQOBZ2	Vemurafenib	Non-small cell lung carcinoma (Cell Line: HOP-92)	[3]
Vismodegib + Picoplatin	DC52921	Vismodegib	Papillary renal cell carcinoma (Cell Line: ACHN)	[3]
Vorinostat + Picoplatin	DCBJINY	Vorinostat	Chronic myelogenous leukemia (Cell Line: KBM-7)	[2]
------------------------------------------------------------------------------------


⏷ Show the Full List of 464 DrugCom(s)

References

1	ClinicalTrials.gov (NCT00465491) Study of Picoplatin Efficacy After Relapse. U.S. National Institutes of Health.
2	Recurrent recessive mutation in deoxyguanosine kinase causes idiopathic noncirrhotic portal hypertension.Hepatology. 2016 Jun;63(6):1977-86. doi: 10.1002/hep.28499. Epub 2016 Mar 31.
3	Loss of function mutations in VARS encoding cytoplasmic valyl-tRNA synthetase cause microcephaly, seizures, and progressive cerebral atrophy.Hum Genet. 2018 Apr;137(4):293-303. doi: 10.1007/s00439-018-1882-3. Epub 2018 Apr 24.
4	Biologically active neutrophil chemokine pattern in tonsillitis.Clin Exp Immunol. 2004 Mar;135(3):511-8. doi: 10.1111/j.1365-2249.2003.02390.x.